SCHEMBL2559620

SCHEMBL2559620

NC(=O)C1CCN(CC=O)CC1

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.60
GAA P10253 3/20 0.44
KDM4E B2RXH2 3/20 0.43
SMYD3 Q9H7B4 1/20 0.41
LTA4H P09960 1/20 0.40
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39
HIF1A Q16665 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3941089 0.82 KDM4E (0.42) SMN1; SMN2KDM4ELTA4HLMNAL3MBTL1
SCHEMBL2563207 0.81 SMN1; SMN2 (0.56) SMN1; SMN2GAAKDM4ESMYD3LTA4H
SCHEMBL5262805 0.80 SMN1; SMN2 (0.41) SMN1; SMN2GAAKDM4EALDH1A1KMT2A
SCHEMBL10177410 0.79 SMN1; SMN2 (0.59) SMN1; SMN2GAAKDM4ESMYD3LTA4H
SCHEMBL2556227 0.78 LTA4H (0.39) SMN1; SMN2GAALTA4H
SCHEMBL2555010 0.78 BCHE (0.55) SMN1; SMN2GAALTA4HALDH1A1MEN1
SCHEMBL29951364 0.77 LTA4H (0.43) SMN1; SMN2LTA4HALDH1A1LMNA
SCHEMBL27362424 0.77 SMN1; SMN2 (0.67) SMN1; SMN2GAAKDM4ESMYD3ALDH1A1
SCHEMBL14067410 0.77 SMN1; SMN2 (0.67) SMN1; SMN2GAAKDM4ESMYD3ALDH1A1
SCHEMBL8651611 0.77 SMN1; SMN2 (0.51) SMN1; SMN2GAAKDM4ELTA4HALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113058577-A Glycopeptide enrichment material and preparation method and enrichment method thereof 苏州大学 2021-07-02 CN claimed
WO-2008133344-A2 PIPERIDINE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-06 WO claimed
CN-113058577-B Glycopeptide enrichment material, preparation method thereof and enrichment method 苏州大学 2024-01-19 CN disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-11225655-B2 Bi-functional complexes and methods for making and using such complexes NUEVOLUTION A/S (DK) 2022-01-18 US disclosed
CN-113058577-A Glycopeptide enrichment material and preparation method and enrichment method thereof 苏州大学 2021-07-02 CN disclosed
EP-3540059-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2019-09-18 EP disclosed
EP-2558577-B1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION AS (DK) 2018-12-12 EP disclosed
US-20130281324-A1 BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2013-10-24 US disclosed
EP-2558577-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2013-02-20 EP disclosed
WO-2011127933-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2011-10-20 WO disclosed
WO-2008133344-A2 PIPERIDINE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-06 WO disclosed